Katharine R. Owen
Research Subjects
Katharine R. Owen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
A. T. Hattersley
Department of Diabetes and Vascular Medicine, Peninsula Medical School, Exeter
2 shared publications- Sian Ellard
Exeter Genomics Laboratory, South West Genomic Medicine Service, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
2 shared publications A. Stride
Centre for Molecular Genetics, School of Post‐graduate Medicine and Health Sciences, University of Exeter, Exeter, UK
1 shared publicationAmanda Stride
From the Peninsula Medical School, Department of Diabetes and Vascular Medicine, Exeter, Devon, U.K
1 shared publicationAndrew Hattersley
From the Department of Diabetes and Vascular Medicine, University of Exeter, Devon, U.K
1 shared publicationAndrew T. Hattersley
From the Peninsula Medical School, Department of Diabetes and Vascular Medicine, Exeter, Devon, U.K
1 shared publication
Latest Publications
- Open Access
- 1 July 2003
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (7) , 2088-2093
Etiological Investigation of Diabetes in Young Adults Presenting With Apparent Type 2 Diabetes
OBJECTIVE—Young adults with newly diagnosed apparent type 2 diabetes present the clinician with a wide differential diagnosis of possible etiology, including autoimmune and genetic causes as well as young-onset type 2 diabetes (YT2D). The characteristics of these groups have been described, but it is not known in which subjects investigation for etiology may be beneficial. RESEARCH DESIGN AND METHODS—A total of 268 unselected U.K. Caucasian subjects diagnosed at ages 18–45 years and not treated with permanent insulin for ≤6 months were studied. All subjects underwent clinical assessment and screening for GAD antibodies (GADA) and tyrosine phosphatase IA-2 antibodies (IA-2A). Screening for a common mutation in the hepatocyte nuclear factor-1α (HNF-1α) gene and the common mitochondrial mutation was performed in the antibody-negative subjects. Subjects without insulin resistance were selected for sequencing of the HNF-1α gene. RESULTS—A specific etiology was defined in 11.6% of the 268 subjects and in 24.7% of the lean subjects. Twenty-six subjects (9.7%) were positive for a β-cell antibody, one subject had familial partial lipodystrophy and the lamin A/C mutation R482W, and two subjects had the mitochondrial mutation A3243G. Two of 15 selected subjects had HNF-1α mutations, the novel missense mutation A501T, and the previously reported R583Q. CONCLUSIONS—This unselected series shows that there is considerable heterogeneity in apparent YT2D. β-Cell autoantibodies should be performed in all those presenting at ages 18–45 years. Genetic investigations can be targeted to phenotypically defined subjects. The finding of a specific etiology will allow individualization of management and give patients valuable information about their condition.
- 1 July 2003
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (7) , 2088-2093
Open AccessEtiological Investigation of Diabetes in Young Adults Presenting With Apparent Type 2 Diabetes
OBJECTIVE—Young adults with newly diagnosed apparent type 2 diabetes present the clinician with a wide differential diagnosis of possible etiology, including autoimmune and genetic causes as well as young-onset type 2 diabetes (YT2D). The characteristics of these groups have been described, but it is not known in which subjects investigation for etiology may be beneficial. RESEARCH DESIGN AND METHODS—A total of 268 unselected U.K. Caucasian subjects diagnosed at ages 18–45 years and not treated with permanent insulin for ≤6 months were studied. All subjects underwent clinical assessment and screening for GAD antibodies (GADA) and tyrosine phosphatase IA-2 antibodies (IA-2A). Screening for a common mutation in the hepatocyte nuclear factor-1α (HNF-1α) gene and the common mitochondrial mutation was performed in the antibody-negative subjects. Subjects without insulin resistance were selected for sequencing of the HNF-1α gene. RESULTS—A specific etiology was defined in 11.6% of the 268 subjects and in 24.7% of the lean subjects. Twenty-six subjects (9.7%) were positive for a β-cell antibody, one subject had familial partial lipodystrophy and the lamin A/C mutation R482W, and two subjects had the mitochondrial mutation A3243G. Two of 15 selected subjects had HNF-1α mutations, the novel missense mutation A501T, and the previously reported R583Q. CONCLUSIONS—This unselected series shows that there is considerable heterogeneity in apparent YT2D. β-Cell autoantibodies should be performed in all those presenting at ages 18–45 years. Genetic investigations can be targeted to phenotypically defined subjects. The finding of a specific etiology will allow individualization of management and give patients valuable information about their condition.
- 1 June 2003
- Published by Wiley in Diabetic Medicine
- Vol. 20 (6) , 483-485
Adolescent onset Type 2 diabetes in a non‐obese Caucasian patient with an unbalanced translocation
Background Childhood onset Type 2 diabetes in the UK has been reported in obese, insulin‐resistant subjects. Investigation is necessary to exclude other aetiologies including genetic causes. The co‐existence of diabetes and a chromosomal breakpoint may indicate the position of novel diabetes genes. Case report We describe a novel unbalanced translocation between Xq and 10p associated with amenorrhoea and onset of Type 2 diabetes in a non‐obese Caucasian adolescent. There was no evidence of an autoimmune or known genetic aetiology for the diabetes and the phenotype was not typical of youth‐onset Type 2. We therefore hypothesize that the translocation is implicated in the aetiology of the diabetes. This is supported by previous reports of diabetes as a feature of Xq deletions and Turner's syndrome and linkage to the Xq region in a genome‐wide scan for Type 2 genes. Conclusion That this region may harbour a gene predisposing to Type 2 diabetes and that cytogenetic studies may be useful in investigating diabetes in children and young adults. Diabet. Med. 20, 483–485 (2003)
- 1 June 2003
- Published by Wiley in Diabetic Medicine
- Vol. 20 (6) , 483-485
Adolescent onset Type 2 diabetes in a non‐obese Caucasian patient with an unbalanced translocation
Background Childhood onset Type 2 diabetes in the UK has been reported in obese, insulin‐resistant subjects. Investigation is necessary to exclude other aetiologies including genetic causes. The co‐existence of diabetes and a chromosomal breakpoint may indicate the position of novel diabetes genes. Case report We describe a novel unbalanced translocation between Xq and 10p associated with amenorrhoea and onset of Type 2 diabetes in a non‐obese Caucasian adolescent. There was no evidence of an autoimmune or known genetic aetiology for the diabetes and the phenotype was not typical of youth‐onset Type 2. We therefore hypothesize that the translocation is implicated in the aetiology of the diabetes. This is supported by previous reports of diabetes as a feature of Xq deletions and Turner's syndrome and linkage to the Xq region in a genome‐wide scan for Type 2 genes. Conclusion That this region may harbour a gene predisposing to Type 2 diabetes and that cytogenetic studies may be useful in investigating diabetes in children and young adults. Diabet. Med. 20, 483–485 (2003)
- 6 September 2002
- Published by Wiley in Diabetic Medicine
- Vol. 19 (9) , 758-761
Heterogeneity in young adult onset diabetes: aetiology alters clinical characteristics
Aims To describe the characteristics of hepatocyte nuclear factor (HNF) 1α mutation carriers diagnosed with diabetes after 25 years and compare them with young‐onset Type 2 diabetic patients (YT2D) diagnosed at the same age.Subjects and methods We studied 44 (21 male, 23 female) patients with HNF‐1α mutations diagnosed with diabetes at ages 25–45 years and 44 YT2D subjects matched for sex and age of diagnosis.Results Median age of onset of diabetes was 35 years in both groups. The HNF‐1α group demonstrated: lower body mass index (25.1 vs. 30.7 kg/m2; P < 0.001) and lower fasting triglycerides (1.37 vs. 2.96 mmol/l; P = 0.001) with similar fasting cholesterol level. They had lower glycated haemoglobin A1c (7.3 vs. 8.5%; P = 0.015) despite greater duration of diabetes (24 vs. 16 years; P = 0.02) and less frequent treatment with insulin (21% vs. 55%; P = 0.002). They were less likely to be treated for hypertension (13.3% vs. 56.3%; P = 0.009). Importantly, no difference was observed in reported parental history of diabetes between the two groups (65.9% vs. 63.6%; P = 0.92). Logistic regression showed that triglyceride levels and presence of anti‐hypertensive treatment were the most important independent variables.Conclusions Patients with HNF‐1α mutations may present with diabetes as young adults between the ages of 25–45 years. In this age range a wide differential diagnosis of diabetes is observed. Conventional criteria of age of onset and family history will not differentiate HNF‐1α mutation carriers from YT2D subjects in this age range, but features of the metabolic syndrome, in particular fasting triglycerides and hypertension, are helpful. In patients diagnosed before 45 years without features of insulin resistance the diagnosis of HNF‐1α should be considered.
- 6 September 2002
- Published by Wiley in Diabetic Medicine
- Vol. 19 (9) , 758-761
Heterogeneity in young adult onset diabetes: aetiology alters clinical characteristics
Aims To describe the characteristics of hepatocyte nuclear factor (HNF) 1α mutation carriers diagnosed with diabetes after 25 years and compare them with young‐onset Type 2 diabetic patients (YT2D) diagnosed at the same age.Subjects and methods We studied 44 (21 male, 23 female) patients with HNF‐1α mutations diagnosed with diabetes at ages 25–45 years and 44 YT2D subjects matched for sex and age of diagnosis.Results Median age of onset of diabetes was 35 years in both groups. The HNF‐1α group demonstrated: lower body mass index (25.1 vs. 30.7 kg/m2; P < 0.001) and lower fasting triglycerides (1.37 vs. 2.96 mmol/l; P = 0.001) with similar fasting cholesterol level. They had lower glycated haemoglobin A1c (7.3 vs. 8.5%; P = 0.015) despite greater duration of diabetes (24 vs. 16 years; P = 0.02) and less frequent treatment with insulin (21% vs. 55%; P = 0.002). They were less likely to be treated for hypertension (13.3% vs. 56.3%; P = 0.009). Importantly, no difference was observed in reported parental history of diabetes between the two groups (65.9% vs. 63.6%; P = 0.92). Logistic regression showed that triglyceride levels and presence of anti‐hypertensive treatment were the most important independent variables.Conclusions Patients with HNF‐1α mutations may present with diabetes as young adults between the ages of 25–45 years. In this age range a wide differential diagnosis of diabetes is observed. Conventional criteria of age of onset and family history will not differentiate HNF‐1α mutation carriers from YT2D subjects in this age range, but features of the metabolic syndrome, in particular fasting triglycerides and hypertension, are helpful. In patients diagnosed before 45 years without features of insulin resistance the diagnosis of HNF‐1α should be considered.
- 1 March 2002
- Published by American Diabetes Association in Diabetes Care
- Vol. 25 (3) , 636-637
Increased Risk of Diabetes in First-Degree Relatives of Young-Onset Type 2 Diabetic Patients Compared With Relatives of Those Diagnosed Later
- 1 March 2002
- Published by American Diabetes Association in Diabetes Care
- Vol. 25 (3) , 636-637
Increased Risk of Diabetes in First-Degree Relatives of Young-Onset Type 2 Diabetic Patients Compared With Relatives of Those Diagnosed Later
- 1 December 2001
- Published by SAGE Publications in Thyroid®
- Vol. 11 (12) , 1187-1190
Multifocal Fibrosclerosis: A Case of Thyroiditis and Bilateral Lacrimal Gland Involvement
A patient with invasive fibrous thyroiditis (Riedel's thyroiditis), dysphagia, and bilateral lacrimal gland involvement is described. Resolution of the thyroid mass and orbital swellings followed corticosteroid therapy. The unusual ocular features of this case are briefly discussed and the use of corticosteroid and other immunosuppressant therapy in multifocal fibrosclerosis is reviewed.
- 1 December 2001
- Published by SAGE Publications in Thyroid®
- Vol. 11 (12) , 1187-1190
Multifocal Fibrosclerosis: A Case of Thyroiditis and Bilateral Lacrimal Gland Involvement
A patient with invasive fibrous thyroiditis (Riedel's thyroiditis), dysphagia, and bilateral lacrimal gland involvement is described. Resolution of the thyroid mass and orbital swellings followed corticosteroid therapy. The unusual ocular features of this case are briefly discussed and the use of corticosteroid and other immunosuppressant therapy in multifocal fibrosclerosis is reviewed.